On February 8, 2019, Gossamer Bio listed on Nasdaq under the ticker “GOSS.” The Hillhouse-backed biotech company raised $276 million in proceeds, and the company saw very healthy interest from investors. Proceeds from the listing were planned to be used to continue funding Gossamer’s innovative product pipeline.
On July 27, 2017, Belle International announced plans to undertake privatization and was delisted from the Hong Kong Stock Exchange . After privatization, Hillhouse held 57.6% of the company, becoming the new controlling shareholder of Belle. In a recent speech, Zhang Lei discussed why Hillhouse invested in Belle and the future plans for the company.
On June 23, Hillhouse’s founder Lei Zhang gave the commencement speech to the graduating class of 2017 at Renmin University of China. Many of the topics shared with the new graduates reflect values that are deeply embedded in Hillhouse’s investment philosophy and organizational culture: orient yourself toward the long-term, be mission-driven, and think from first principles.